Background : Endoscopic retrograde cholangiopancreatography (ERCP) often requires deep sedation because it is an invasive procedure. Dexmedetomidine (DEX), a highly selective α2-adrenoceptor agonist with sedative activity and minimal effects on respiration, has recently been widely used for patients in the intensive care unit. However, its utility for endoscopic procedures remains unclear. In this study, we retrospectively investigated the safety and efficacy of dexmedetomidine sedation during ERCP.
Methods : Among the patients who underwent ERCP from January 2013, eighty-six patients were sedated with dexmedetomidine (i.v. infusion of 3.0μg/kg/hr over 10 min followed by continuous infusion at 0.4μg/kg/hr) with the addition of midazolam and pentazocine. As a control group, we collected patients who underwent ERCP before January 2013 and who were sedated with midazolam and pentazocine without DEX. Additionally, pentazocine, midazolam and propofol were administered as needed to maintain Ramsay sedation scale 4. Elderly patients (above 81 years old) and patients with reduced cardiac function were excluded from this study. Outcome measures were the amounts of midazolam and pentazocine administered, adverse events associated with sedation, and hemodynamics.
Results : The incidence rate of decreased SpO
2 was significantly lower (3.5% vs. 11.6%,
p=0.04) and the median dose of additional midazolam and pentazocine was significantly lower in the DEX group than in the control group (5.2mg vs. 12.5mg;
p<0.001, 7.5mg vs. 11.4mg ;
p<0.001). There was no case in which propofol was needed or the procedure was discontinued because of respiratory depression in the DEX group. Blood pressure and pulse rate were significantly lower in the DEX group than in the control group. However, no case required a vasopressor.
Conclusions : Dexmedetomidine reduced the incidence of respiratory complications and total dose of other sedative agents. Dexmedetomidine can be used as an alternative to conventional methods for adequate sedation during ERCP.
View full abstract